GLP1R and type 2 diabetes mellitus: The aim of this article is to review the current clinical evidence for liraglutide compared with other injectable therapies commonly initiated after failure of oral therapy, including other GLP-1 mimetics and basal insulin within the context of the NICE guidelines, in order to provide further guidance to physicians treating patients with T2DM who have failed on oral therapy.